Moreover, the genetic deficiency of Hippo signaling (such as loss of MST1/2) activates YAP to generate a pro-tumorigenic environment that alters macrophage recruitment and immune responses facilitating the development of HCC [113,114,115,116]. The gene discussed is YAP1; the disease is hepatocellular carcinoma.